Moderna, Inc. (NASDAQ:MRNA)

PRESS RELEASE

published on 02/01/2024 at 13:00, 2 years 3 months ago

Moderna to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 22, 2024
Moderna, Inc. to report Q4 and full year 2023 financial results and provide corporate update in live conference call and webcast on February 22, 2024. Archived webcast available for one year

Financial Results Conference Call Moderna Inc Webcast MRNA Medicine
PRESS RELEASE

published on 01/31/2024 at 23:45, 2 years 3 months ago

Moderna Named to Fortune's List of World's Most Admired Companies
Moderna, Inc. has been recognized on Fortune's World's Most Admired Companies list, positioning among the top-50 companies. The company focuses on mRNA medicine for disease prevention and treatment, recognized for innovation and public health impact

Moderna Inc. Fortune Most Admired Companies MRNA Medicine Corporate Reputation
PRESS RELEASE

published on 01/08/2024 at 13:00, 2 years 4 months ago

Moderna Provides Business and Pipeline Updates at 42nd Annual J.P. Morgan Healthcare Conference
Moderna, Inc. (NASDAQ: MRNA) announces impressive financial updates for 2023, with approximately $6.7 billion in product sales and an increased COVID-19 market share in the U.S. The company reiterates the expectation of approximately $4 billion in product sales for 2024, highlighting upcoming late-stage programs with anticipated milestones in 2024 and 2025. The nine late-stage programs include respiratory vaccines, next-generation COVID-19 vaccine, seasonal flu vaccine, combination vaccine against seasonal flu and COVID-19, cytomegalovirus (CMV) vaccine, individualized neoantigen therapy (INT), and rare disease therapeutics. Moderna focuses on returning to sales growth in 2025 and expects to break even in 2026 through product launches and disciplined investment. For further details, Jamey Mock will present an update on the Company and its pipeline of mRNA development programs at the 42nd Annual J.P. Morgan Healthcare Conference on January 8th, 2024, at 3:45 p.m. PT/6:45 p.m. ET.

Moderna Inc Financial Updates COVID-19 Market Share Late-stage Programs MRNA Development Programs
PRESS RELEASE

published on 12/20/2023 at 22:05, 2 years 4 months ago

Moderna to Present at the 42nd Annual J.P. Morgan Healthcare Conference
PRESS RELEASE

published on 12/15/2023 at 00:00, 2 years 4 months ago

Moderna Announces New England Journal of Medicine Publication of Pivotal Phase 3 Clinical Safety and Efficacy Data For MRNA-1345, The Company’s Investigational Respiratory Syncytial Virus (RSV) Vaccine
PRESS RELEASE

published on 12/14/2023 at 12:30, 2 years 4 months ago

Moderna And Merck Announce mRNA-4157 (V940) In Combination with Keytruda(R) (Pembrolizumab) Demonstrated Continued Improvement in Recurrence-Free Survival and Distant Metastasis-Free Survival in Patients with High-Risk Stage III/IV Melanoma Following Comp
PRESS RELEASE

published on 12/12/2023 at 14:00, 2 years 5 months ago

Moderna Announces Changes to Commercial Organization to Prepare for Multiple Product Launches in 2024 and 2025
PRESS RELEASE

published on 12/07/2023 at 13:00, 2 years 5 months ago

Moderna Reviews its Environmental, Social and Governance (ESG) Progress and Ambitions at Second ESG Investor Event
PRESS RELEASE

published on 11/14/2023 at 13:00, 2 years 5 months ago

Moderna to Host Second Environmental, Social and Governance (ESG) Investor Event on December 7th, 2023
PRESS RELEASE

published on 11/08/2023 at 22:15, 2 years 6 months ago

Moderna to Present at Upcoming Conferences in November 2023

Published on 05/12/2026 at 14:30, 2 hours 40 minutes ago

Pathfinder Ventures Inc. Announces Conclusion of Financing and Intention to Launch New Private Placement
Published on 05/12/2026 at 14:30, 2 hours 40 minutes ago

ACCESS Newswire Reports First Quarter 2026 Results
Published on 05/12/2026 at 13:50, 3 hours 20 minutes ago

Polaris Renewable Energy Announces Approval of SO1 Agreement by FOMB
Published on 05/12/2026 at 13:30, 3 hours 40 minutes ago

Silver X Mining Begins Trading on OTCQX, Expanding Access to U.S. Investors
Published on 05/12/2026 at 13:30, 3 hours 40 minutes ago

Electric Metals Launches Preliminary Economic Assessment for North Star Manganese Project Downstream HPMSM and EMM Processing Facilities

View all ACCESSWIRE

Published on 05/12/2026 at 17:02, 8 minutes ago

OHB Space UK: Growth, European Cooperation and a Major Contract Win
Published on 05/12/2026 at 16:55, 14 minutes ago

Huawei Launches "Advancing Smart Retail Across Europe" Program to Accelerate Transformation
Published on 05/12/2026 at 16:49, 21 minutes ago

EQS-Adhoc: M1 Kliniken AG: Supervisory Board adopts annual financial statements 2025. Dividend proposal of EUR 1.20 per share
Published on 05/12/2026 at 16:41, 28 minutes ago

Original-Research: Deutz AG (von Quirin Privatbank Kapitalmarktgeschäft): BUY
Published on 05/12/2026 at 16:30, 39 minutes ago

Stabilization Notice

View all EQS

Published on 05/12/2026 at 16:39, 30 minutes ago

NRJ Group - Attribution de 20 licences FM régionales à NRJ Suède
Published on 05/12/2026 at 16:30, 39 minutes ago

AGM 12 may 2026 - Quorum and results
Published on 05/12/2026 at 16:30, 39 minutes ago

AGM 12 mai 2026 - Quorum et résultat des votes
Published on 05/12/2026 at 15:20, 1 hour 49 minutes ago

Mersen: Annual General Meeting of May 12, 2026
Published on 05/12/2026 at 15:20, 1 hour 49 minutes ago

Mersen : Assemblée Générale mixte du 12 mai 2026

View all LES ECHOS COMFI WIRE

News